New Drug Development & Regulatory News
PeopleImages.com - Yuri A Shutterstock
NEC announces interim results from Phase 1 clinical trial
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1. Read more
20 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Studio Romantic Shutterstock
iOnctura reaches new clinical milestones in uveal melanoma
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, provides a clinical update on its lead asset, roginolisib. Read more
18 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
PanuShot Shutterstock
Ellipses Pharma publishes data from phase 1/2 clinical trial of EP0042
Ellipses Pharma has published the latest data from an ongoing Phase 1/2 clinical trial of EP0042, an orally available novel agent that targets the Aurora kinase axis, in patients with acute myeloid leukaemia (AML). Read more
13 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
13_Phunkod Shutterstock
Companies partner to advance X-ray crystallography in early drug discovery
UK-based Concept Life Sciences (Concept) and Accelero Biostructures (Accelero) in the US have formed a partnership which will help pharma businesses worldwide speed up drug development by up to tenfold. Read more
11 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Photon photo Shutterstock
Hua Medicine announces successful U.S. Phase I results
Hua Medicine has announced that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC). Read more
4 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
ISPOR
New tool launched to help navigate incoming JCA regulations
Human Data Sciences (HDS), a data science analytics company based in the UK, unveiled new tools that will make it easier for pharmaceutical companies to navigate the incoming Joint Clinical Assessment (JCA) regulations at the ISPOR conference. Read more
29 Nov 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Astoriom
Astoriom launches dedicated cryo-storage suite
Astoriom has developed a new cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland. Read more
18 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
PanuShot Shutterstock
Ellipses Pharma publishes data from phase 1/2 clinical trial of EP0042
Ellipses Pharma has published the latest data from an ongoing Phase 1/2 clinical trial of EP0042, an orally available novel agent that targets the Aurora kinase axis, in patients with acute myeloid leukaemia (AML). Read more
13 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Marc Bruxelle Shutterstock
NHS launches anti-smoking pill to help thousands quit
As part of the UK government's efforts to create a smoke-free generation, the National Health Service (NHS) England is rolling out a new and improved pill to help people stop smoking, giving thousands of smokers a better chance to quit for good. Read more
11 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
GreenOak Shutterstock
How Adragos is building a more resilient pharma supply chain
The global pharmaceutical industry is facing unprecedented supply chain challenges in the current climate of geopolitical uncertainty. Marco Gorgas, chief technical officer, Adragos Pharma explains. Read more
20 Dec 2024
Pharma Manufacturing News + Pharmaceutical Logistics & Distribution News
BOY ANTHONY Shutterstock
Neuraxpharm and Pharmathen enter into strategic co-development agreement
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
PeopleImages.com - Yuri A Shutterstock
NEC announces interim results from Phase 1 clinical trial
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1. Read more
20 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Freudenberg
Freudenberg Sealing Technologies enhances safety of modern lithium-ion batteries
Freudenberg Sealing Technologies is working on enhancing the safety of modern lithium-ion batteries, thereby advancing the future of electromobility. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Ahmed Hamaki Shutterstock
Mary Marcus appointed CEO of NewAge Industries
NewAge Industries, parent company of AdvantaPure and NewAge Performance Products, has announced the appointment of Mary Marcus to the position of CEO. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Phastar
Phastar scoops 2024 Scrip Award
Phastar, a specialist biometrics contract research organisation (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
